We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+1.52%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$486B
AUM Growth
+$2.12B
Cap. Flow
+$867M
Cap. Flow %
0.18%
Top 10 Hldgs %
13.96%
Holding
2,615
New
76
Increased
1,051
Reduced
777
Closed
79

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$3.76B
2
CI icon
Cigna
CI
+$1.44B
3
BMY icon
Bristol-Myers Squibb
BMY
+$1.26B
4
OXY icon
Occidental Petroleum
OXY
+$763M
5
DHR icon
Danaher
DHR
+$762M

Sector Composition

Rank Sector Weight
1 Healthcare 22.87%
2 Financials 13.64%
3 Consumer Discretionary 13.54%
4 Industrials 10.67%
5 Technology 10.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
REIS
2076
DELISTED
Reis, Inc.
REIS
$393K ﹤0.01%
17,700
STL
2077
DELISTED
Sterling Bancorp
STL
$393K ﹤0.01%
26,740
CYBX
2078
DELISTED
CYBERONICS INC
CYBX
$392K ﹤0.01%
6,600
GABC icon
2079
German American Bancorp
GABC
$1.91B
$391K ﹤0.01%
19,895
GOV
2080
DELISTED
Government Properties Income Trust
GOV
$391K ﹤0.01%
21,100
+9,400
+80% +$192K
SHEN icon
2081
Shenandoah Telecom
SHEN
$721M
$390K ﹤0.01%
22,800
SGYP
2082
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$390K ﹤0.01%
47,000
ALJ
2083
DELISTED
Alon USA Energy Inc
ALJ
$389K ﹤0.01%
20,604
+7,400
+56% +$126K
SBRA icon
2084
Sabra Healthcare REIT
SBRA
$5.16B
$387K ﹤0.01%
15,033
LOGM
2085
DELISTED
LogMein, Inc.
LOGM
$387K ﹤0.01%
6,000
PAG icon
2086
Penske Automotive Group
PAG
$14.3B
$386K ﹤0.01%
7,416
RGR icon
2087
Sturm, Ruger & Co
RGR
$600M
$385K ﹤0.01%
6,700
LORL
2088
DELISTED
Loral Space and Communications, Inc.
LORL
$385K ﹤0.01%
6,100
+1,100
+22% +$74.2K
BCO icon
2089
Brink's
BCO
$4.69B
$384K ﹤0.01%
13,049
SPXC icon
2090
SPX Corp
SPXC
$10.9B
$384K ﹤0.01%
21,066
MWW
2091
DELISTED
Monster Worldwide Inc
MWW
$384K ﹤0.01%
58,700
GERN icon
2092
Geron
GERN
$1.01B
$383K ﹤0.01%
89,400
+29,500
+49% +$117K
WAC
2093
DELISTED
Walter Investment Mgt Corp
WAC
$383K ﹤0.01%
16,768
+580
+4% +$11.1K
AIR icon
2094
AAR Corp
AIR
$5.96B
$382K ﹤0.01%
12,000
TMP icon
2095
Tompkins Financial
TMP
$1.44B
$382K ﹤0.01%
7,111
POWI icon
2096
Power Integrations
POWI
$3.57B
$380K ﹤0.01%
16,800
HOV icon
2097
Hovnanian Enterprises
HOV
$793M
$379K ﹤0.01%
5,693
+1,692
+42% +$133K
ELGX
2098
DELISTED
Endologix Inc
ELGX
$379K ﹤0.01%
2,470
OMG
2099
DELISTED
OM GROUP INC.
OMG
$378K ﹤0.01%
11,250
LNN icon
2100
Lindsay Corp
LNN
$1.18B
$374K ﹤0.01%
4,250

Similar funds

T. Rowe Price Associates's Q2 2015 Portfolio in Review

As of Q2 2015, T. Rowe Price Associates held 2,615 positions worth $486B, up 0.44% from $484B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

T. Rowe Price Associates's Q2 2015 filing shows 76 new, 1,051 increased, 777 reduced and 79 closed positions. Its largest new stake was Allergan plc: 548,825 shares worth $570M. The largest sale was PHARMACYCLICS INC, an estimated $2.46B.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Financials and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q2 2015 buy was Allergan plc: 548,825 shares worth $570M.
  • T. Rowe Price Associates added most to Microsoft in Q2 2015, an estimated $3.76B increase.
  • T. Rowe Price Associates's biggest Q2 2015 reduction was Wynn Resorts, cutting an estimated $1.11B.
  • T. Rowe Price Associates fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $2.46B.
  • T. Rowe Price Associates's ten largest holdings make up 14% of its $486B portfolio in Q2 2015.
  • T. Rowe Price Associates opened 76 new positions and closed 79 in Q2 2015.
  • T. Rowe Price Associates's portfolio value rose 0.44% quarter-over-quarter to $486B.

Based on T. Rowe Price Associates's 13F filing for Q2 2015, filed 14 Aug 2015.